These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 39120730)

  • 21. Identification and Functional Characterization of a Novel Fc Gamma-Binding Glycoprotein in Rhesus Cytomegalovirus.
    Kolb P; Sijmons S; McArdle MR; Taher H; Womack J; Hughes C; Ventura A; Jarvis MA; Stahl-Hennig C; Hansen S; Picker LJ; Malouli D; Hengel H; Früh K
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The game between host antiviral innate immunity and immune evasion strategies of senecavirus A - A cell biological perspective.
    Zhao K; Zhang S; Liu X; Guo X; Guo Z; Zhang X; Yuan W
    Front Immunol; 2022; 13():1107173. PubMed ID: 36618383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How Dengue Virus Circumvents Innate Immunity.
    Kao YT; Lai MMC; Yu CY
    Front Immunol; 2018; 9():2860. PubMed ID: 30564245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies.
    Zhang S; Wang L; Cheng G
    Mol Ther; 2022 May; 30(5):1869-1884. PubMed ID: 35176485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Definition Analysis of Host Protein Stability during Human Cytomegalovirus Infection Reveals Antiviral Factors and Viral Evasion Mechanisms.
    Nightingale K; Lin KM; Ravenhill BJ; Davies C; Nobre L; Fielding CA; Ruckova E; Fletcher-Etherington A; Soday L; Nichols H; Sugrue D; Wang ECY; Moreno P; Umrania Y; Huttlin EL; Antrobus R; Davison AJ; Wilkinson GWG; Stanton RJ; Tomasec P; Weekes MP
    Cell Host Microbe; 2018 Sep; 24(3):447-460.e11. PubMed ID: 30122656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV.
    Carbone J
    Transplantation; 2016 Mar; 100 Suppl 3(Suppl 3):S11-8. PubMed ID: 26900990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response.
    Rodríguez Pulido M; Sáiz M
    Front Cell Infect Microbiol; 2017; 7():252. PubMed ID: 28660175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Cytomegalovirus Protein UL94 Targets MITA to Evade the Antiviral Immune Response.
    Zou HM; Huang ZF; Yang Y; Luo WW; Wang SY; Luo MH; Fu YZ; Wang YY
    J Virol; 2020 Jun; 94(12):. PubMed ID: 32238587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency.
    Sabbaghian M; Gheitasi H; Fadaee M; Javadi Henafard H; Tavakoli A; Shekarchi AA; Poortahmasebi V
    Arch Virol; 2024 Jul; 169(8):157. PubMed ID: 38969819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection.
    Kropp KA; Hsieh WY; Isern E; Forster T; Krause E; Brune W; Angulo A; Ghazal P
    PLoS Pathog; 2015 Apr; 11(4):e1004737. PubMed ID: 25856589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors.
    Pyzik M; Gendron-Pontbriand EM; Fodil-Cornu N; Vidal SM
    Mamm Genome; 2011 Feb; 22(1-2):6-18. PubMed ID: 20882286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of antiviral innate immune signaling and viral evasion following viral genome sensing.
    Chathuranga K; Weerawardhana A; Dodantenna N; Lee JS
    Exp Mol Med; 2021 Nov; 53(11):1647-1668. PubMed ID: 34782737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
    Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
    J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evasion of host antiviral innate immunity by HSV-1, an update.
    Su C; Zhan G; Zheng C
    Virol J; 2016 Mar; 13():38. PubMed ID: 26952111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways.
    Rajsbaum R; García-Sastre A
    Trends Microbiol; 2013 Aug; 21(8):421-9. PubMed ID: 23850008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.
    Rölle A; Olweus J
    APMIS; 2009 May; 117(5-6):413-26. PubMed ID: 19400865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of the innate immune response by human cytomegalovirus.
    Biolatti M; Gugliesi F; Dell'Oste V; Landolfo S
    Infect Genet Evol; 2018 Oct; 64():105-114. PubMed ID: 29935337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: facts and thoughts based on murine models.
    Lemmermann NA; Böhm V; Holtappels R; Reddehase MJ
    Virus Res; 2011 May; 157(2):161-74. PubMed ID: 20933556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlling cytomegalovirus: helping the immune system take the lead.
    Hanley PJ; Bollard CM
    Viruses; 2014 May; 6(6):2242-58. PubMed ID: 24872114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
    Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.